Risk factors for early-onset ventilator-associated pneumonia in aneurysmal subarachnoid hemorrhage patients
Cui, J.B., Chen, Q.Q., Liu, T.T., Li, S.J.
Braz J Med Biol Res
DATA DE PUBLICAÇÃO
This study aimed to investigate the risk factors related to ventilator-acquired pneumonia (VAP) in aneurysmal subarachnoid hemorrhage (SAH) patients. From January 2011 to December 2015, a single-center retrospective study including 200 SAH patients requiring mechanical ventilation (MV) ≥48 h was performed. The clinical data of these patients were collected and analyzed. The age range of the patients were 41–63 and 72 (36%) were male. The Glasgow coma scale score range was 5–15 and the Simplified Acute Physiology Score II range was 31–52. One hundred and forty-eight (74%) patients had a World Federation of Neurosurgeons (WNFS) score ≥III. Aneurysm was secured with an endovascular coiling procedure in 168 (84%) patients and 94 (47%) patients presented VAP. Male gender (OR=2.25, 95%CI=1.15–4.45), use of mannitol (OR=3.02, 95%CI=1.53–5.94) and enteral feeding above 20 kcal·kg−1·day−1 (OR=2.90, 95%CI=1.26–6.67) after day 7 were independent factors for VAP. Patients with early-onset VAP had a longer duration of sedation (P=0.03), MV (P=0.001) and ICU length of stay (P=0.003) and a worse Glasgow Outcome Scale score (P<0.001), but did not have a higher death rate.
- Retraction notice for: “Risk factors for early-onset ventilator-associated pneumonia in aneurysmal subarachnoid hemorrhage patients” [Braz J Med Biol Res (2018) 51(7): e6830]
- Risk factors for mortality in patients with ventilator-associated pneumonia caused by carbapenem-resistant Enterobacteriaceae
- Ventilator-associated pneumonia and oral health
- Cost effectiveness in treating ventilator-associated pneumonia
- Antibody response to Prevotella spp. in patients with ventilator-associated pneumonia.